BioEquity Europe 2010
May 19, 2010 Zuricht, Switzerland
Dr Manja Bouman, CEO, has presented
BioCapital Europe 2010
April 29, 2010 Amsterdam, The Netherlands
VP Business Development of Kiadis Pharma, Stefaan Allemeersch, has presented
BioEquity Europe 2009
June 9-10, 2009 Munich, Germany
Dr Manja Bouman, CEO, has presented
BioCapital Europe 2009
April 21, 2009 Amsterdam, The Netherlands
Dr Manja Bouman, CEO, has presented
ISCT Global Regulatory Perspectives Workshop
May 23, 1020, Philadelphia, USA
Vice President Clinical Development of Kiadis Pharma, Dr. Edwin Wagena, has presented
ASH Annual Meeting and Exposition
December 5 - 8, 2009 New Orleans, USA
Delegates of Kiadis Pharma has visited this conference
EBMT Göteborg, Sweden
March 29 March - 1 April 2009
Kiadis Pharma's principal investigators have presented.
PDF Abstracts EBMT Satellite Symposium
BMT tandem meetings
February 11-15, 2009 Tampa, USA
Clinical phase I/II trial results of Kiadis Pharma's lead product ATIR™ were presented by its principal investigator Dr. Denis Claude Roy
ASH Annual Meeting and Exposition
December 6 - 9 2008 San Francisco, USA
Delegates of Kiadis Pharma visited this conference
The Biopharmaceutical Conference in Europe, 2008
June 11 -13 2008, Rome, Italy
Delegates from Kiadis Pharma visited this conference
